Ari Tolonen

3.4k citations
76 papers · 2.7k indexed · h-index 32
Topics
Pharmacogenetics and Drug Metabolism (36 papers)Drug Transport and Resistance Mechanisms (16 papers)Drug-Induced Hepatotoxicity and Protection (14 papers)

In The Last Decade

Ari Tolonen

75 papers receiving 2.6k citations

Peers

Ari Tolonen
Comparison fields: 5 of 124
  • Molecular Biology 1.1k
  • Pharmacology 955
  • Plant Science 628
  • Oncology 326
  • Biochemistry 312
Replace Dejan Nikolić with:
Dejan Nikolić United States
Huidi Jiang China
Kenji Mizutani Japan
Jong Seong Kang South Korea
Maged S. Abdel‐Kader Saudi Arabia
Kitaro Oka Japan
Eva Anzenbacherová Czechia
Nicole H.P. Cnubben Netherlands
Charlotte Simmler United States
Vilı́m Šimánek Czechia
Ari Tolonen relative to Dejan Nikolić United States Dejan Nikolić's profile →
Citations per field
00.5×3.0×
Dejan Nikolić · 1×
Citations per year

Countries citing papers authored by Ari Tolonen

Since Specialization
Citations

This map shows the geographic impact of Ari Tolonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Tolonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Tolonen more than expected).

Fields of papers citing papers by Ari Tolonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ari Tolonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Tolonen. The network helps show where Ari Tolonen may publish in the future.

Co-authorship network of co-authors of Ari Tolonen

This figure shows the co-authorship network connecting the top 25 collaborators of Ari Tolonen. A scholar is included among the top collaborators of Ari Tolonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ari Tolonen. Ari Tolonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 16
4 3
5 35
6 2
7 12
8 77
9 18
10 44
11 16
12 218
13 19
14 99
15 35
16 34
17 81
18 56
19 91
20 28

About Ari Tolonen

Ari Tolonen is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 76 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (36 papers), Drug Transport and Resistance Mechanisms (16 papers) and Drug-Induced Hepatotoxicity and Protection (14 papers). The work is most often cited by research in Pharmacology (955 citations), Biochemistry (312 citations) and Plant Science (628 citations). Ari Tolonen has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Miia Turpeinen, Olavi Pelkonen, Jouko Uusitalo, Jorma Jalonen, Sampo Mattila, Anja Hohtola, Juho Hokkanen, Aleksanteri Petsalo, Anna Maria Pirttilä and Christophe Chesné. Their work appears in journals such as Chemistry of Materials, Analytical Biochemistry and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026